Latest Breaking News On - Path melanoma - Page 1 : comparemela.com

Castle Biosciences Reports First Quarter 2024 Results

Q1 2024 revenue increased 74% over Q1 2023 to $73 million Q1 2024 total test reports increased 40% over Q1 2023 Raising full-year 2024 revenue guidance to $255-265 million from $235-240.

United statesCastle biosciencesDerek maetzoldProgram registriesMental healthSee the companySecurities exchangeCastle biosciences incNational cancer institute surveillanceNational comprehensive cancer networkAmerican joint committee on cancer staging manualMedicare contractorsDecisiondx melanoma classQuarter ended marchPath melanomaAdjusted gross margin

Castle Biosciences Reports First Quarter 2024 Results

Castle Biosciences Reports First Quarter 2024 Results
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United statesCastle biosciencesProgram registriesNational cancer institute surveillanceSee the companyCastle biosciences incSecurities exchangeNational comprehensive cancer networkAmerican joint committee on cancer staging manualMental healthMedicare contractorsDecisiondx melanoma classQuarter ended marchPath melanomaCypher barrettAdjusted gross margin

Castle Biosciences Reports Fourth Quarter and Full-Year 2023 Results

Castle Biosciences Reports Fourth Quarter and Full-Year 2023 Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCamilla zuckeroCastle biosciencesKristen oelschlagerDerek maetzoldProgram registriesMental healthHealthcare technology report topCastle biosciences incSee the companySecurities exchangeNational cancer institute surveillanceAmerican joint committee on cancerNational comprehensive cancer networkMonths endedCypher barrett

BioNexus Gene Lab (NASDAQ:BGLC) vs Castle Biosciences (NASDAQ:CSTL) Critical Comparison

BioNexus Gene Lab (NASDAQ:BGLC) vs Castle Biosciences (NASDAQ:CSTL) Critical Comparison
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Republic ofUnited statesKuala lumpurCastle biosciencesCastle bioscienceDecisiondx diffdxNews ratings for bionexus gene lab dailyCastle biosciences incBionexus gene labBionexus gene lab sdnChemrex corporation sdnBionexus gene lab corpGet free reportGiven castle bioscienceBionexus geneNexus gene lab

Castle Biosciences (NASDAQ:CSTL) versus BioNexus Gene Lab (NASDAQ:BGLC) Head to Head Review

Castle Biosciences (NASDAQ:CSTL) versus BioNexus Gene Lab (NASDAQ:BGLC) Head to Head Review
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesKuala lumpurRepublic ofDecisiondx diffdxCastle bioscienceCastle biosciencesBionexus gene labBionexus gene lab sdnBionexus gene lab corpChemrex corporation sdnCastle biosciences incGet free reportNexus gene labGiven castle bioscienceBionexus geneDecisiondx diffdx melanoma